CARAVITA, SERGIO
 Distribuzione geografica
Continente #
NA - Nord America 7.980
AS - Asia 5.284
EU - Europa 3.557
SA - Sud America 1.205
Continente sconosciuto - Info sul continente non disponibili 290
AF - Africa 149
OC - Oceania 15
Totale 18.480
Nazione #
US - Stati Uniti d'America 7.471
SG - Singapore 1.527
VN - Vietnam 1.395
CN - Cina 956
IT - Italia 764
BR - Brasile 677
DE - Germania 672
HK - Hong Kong 547
RU - Federazione Russa 531
SE - Svezia 450
CA - Canada 293
IE - Irlanda 282
GB - Regno Unito 195
IN - India 150
FR - Francia 149
BD - Bangladesh 141
PE - Perù 132
MX - Messico 126
ID - Indonesia 97
UA - Ucraina 93
ES - Italia 88
EC - Ecuador 82
CL - Cile 79
AR - Argentina 72
FI - Finlandia 69
BO - Bolivia 60
KR - Corea 60
TR - Turchia 58
CO - Colombia 55
AT - Austria 54
ZA - Sudafrica 54
IQ - Iraq 50
PL - Polonia 50
JP - Giappone 48
PK - Pakistan 38
NL - Olanda 32
SA - Arabia Saudita 30
VE - Venezuela 26
PH - Filippine 25
CR - Costa Rica 24
CH - Svizzera 23
UZ - Uzbekistan 23
EG - Egitto 18
AE - Emirati Arabi Uniti 17
BE - Belgio 17
LT - Lituania 17
MA - Marocco 15
MY - Malesia 15
AU - Australia 14
JM - Giamaica 14
TN - Tunisia 13
JO - Giordania 12
PY - Paraguay 12
TW - Taiwan 12
DK - Danimarca 11
RO - Romania 11
IL - Israele 10
NP - Nepal 10
KE - Kenya 8
OM - Oman 8
TH - Thailandia 8
UY - Uruguay 8
HN - Honduras 7
KZ - Kazakistan 7
NI - Nicaragua 7
AL - Albania 6
AO - Angola 6
AZ - Azerbaigian 6
DZ - Algeria 6
ET - Etiopia 6
GR - Grecia 6
GT - Guatemala 6
IR - Iran 6
AM - Armenia 5
BG - Bulgaria 5
HU - Ungheria 5
PA - Panama 5
SV - El Salvador 5
CU - Cuba 4
CZ - Repubblica Ceca 4
LK - Sri Lanka 4
LY - Libia 4
NO - Norvegia 4
TT - Trinidad e Tobago 4
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
EU - Europa 3
GA - Gabon 3
GD - Grenada 3
GE - Georgia 3
KG - Kirghizistan 3
LB - Libano 3
LV - Lettonia 3
NG - Nigeria 3
PR - Porto Rico 3
BB - Barbados 2
BY - Bielorussia 2
HR - Croazia 2
KW - Kuwait 2
LU - Lussemburgo 2
Totale 18.159
Città #
Singapore 888
Ashburn 881
Ann Arbor 657
San Jose 612
Hong Kong 522
Frankfurt am Main 496
Ho Chi Minh City 423
Hanoi 354
Fairfield 318
Chandler 307
Dublin 274
New York 248
Milan 212
Los Angeles 209
Toronto 204
Dallas 195
Woodbridge 190
Houston 173
Santa Clara 165
Council Bluffs 161
Wilmington 151
Beijing 136
Hefei 123
Seattle 122
Chicago 119
Dearborn 103
Cambridge 95
São Paulo 92
Princeton 87
Shanghai 80
Jacksonville 75
The Dalles 71
Lima 65
Jakarta 60
Da Nang 58
Seoul 57
Buffalo 53
Moscow 53
Rome 52
Boardman 50
Lauterbourg 50
Phoenix 48
Denver 45
Haiphong 45
Helsinki 43
Nanjing 43
Columbus 42
Munich 40
La Paz 38
Lawrence 38
Quito 36
Santiago 36
Altamura 35
San Diego 35
Vienna 35
Warsaw 35
Atlanta 34
Montreal 34
Tokyo 34
Johannesburg 32
Chennai 31
Orem 31
Brooklyn 29
London 29
San Francisco 27
Dong Ket 25
Washington 25
Guangzhou 24
Ha Long 23
Ninh Bình 23
Rio de Janeiro 23
Stockholm 22
Nuremberg 21
Baghdad 20
Bogotá 20
Mexico City 20
Poplar 20
Arequipa 19
Guayaquil 19
Quận Bình Thạnh 19
Boston 18
Nanchang 18
Naples 18
Thái Nguyên 18
Biên Hòa 17
Dhaka 17
Hải Dương 17
San José 17
Tashkent 17
Brussels 16
Manchester 16
Can Tho 15
Madrid 15
Salt Lake City 15
Turin 15
Vũng Tàu 15
Bắc Ninh 14
City of London 14
Istanbul 14
Paris 14
Totale 10.759
Nome #
Blood pressure and high altitude: physiological response and clinical management [Presión arterial y altitud: respuestas fisiológicas y manejo clínico] 1.120
Discrepancy in the Diagnosis of Heart Failure with Preserved Ejection Fraction between Supine Versus Upright Exercise Hemodynamic Testing 535
Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation 493
Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test 397
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 376
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 374
Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study 354
The Added Value of 3-Dimensional Echocardiography to Understand the Pathophysiology of Functional Tricuspid Regurgitation 347
Heart failure and anemia: Effects on prognostic variables 346
Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude 337
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 335
Role of acetazolamide and telmisartan/nifedipine-GITS combination in antagonizing the blood pressure rise induced by high altitude exposure 326
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison 317
Pulmonary artery wedge pressure and left ventricular end-diastolic pressure during exercise in patients with dyspnoea 305
Exercise haemodynamics in heart failure with preserved ejection fraction: a systematic review and meta-analysis 303
Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure With Preserved Ejection Fraction 303
Ambulatory Blood Pressure in Untreated and Treated Hypertensive Patients at High Altitude: The High Altitude Cardiovascular Research-Andes Study 302
Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization 302
Blood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment Effects 301
Acute high altitude exposure reduces lung diffusion without evidence of alveolar capillary membrane damage. Evidence from the HIGHCARE Alps Project. 295
Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: A meta-analysis 295
Incremental Value of Right Atrial Strain Analysis to Predict Atrial Fibrillation Recurrence After Electrical Cardioversion 294
Right Ventricular Function and Outcomes Stratified by the Effective Regurgitant Orifice Area in Secondary Tricuspid Regurgitation 294
Assessment of left ventricular diastolic function by three-dimensional transthoracic echocardiography 294
Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component 292
Pulmonary congestion at rest and abnormal ventilation during exercise in chronic systolic heart failure 287
Atrial Functional Tricuspid Regurgitation as a Distinct Pathophysiological and Clinical Entity: No Idiopathic Tricuspid Regurgitation Anymore 286
Ischemic changes in exercise ECG in a hypertensive subject acutely exposed to high altitude. Possible role of a high-altitude induced imbalance in myocardial oxygen supply-demand. 285
Corrigendum: The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype (Front. Cardiovasc. Med., (2022), 9, 1022755, 10.3389/fcvm.2022.1022755) 283
Blood pressure at high altitude: Physiology and clinical implications 280
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 274
Recent advances in multimodality imaging of the tricuspid valve 274
Corrigendum to 'Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps Project' [Respir. Physiol. Neurobiol. 188, (2013), 223-228] 271
Upward shift and steepening of the blood pressure response to exercise in hypertensive subjects at high altitude 266
Heart failure and sleep related breathing disorders: Data from PROMISES (Progetto Multicentrico Italiano Sonno e Scompenso Cardiaco) study 263
Clinical Value of a Novel Three-Dimensional Echocardiography–Derived Index of Right Ventricle–Pulmonary Artery Coupling in Tricuspid Regurgitation 259
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 255
Impact of severe secondary tricuspid regurgitation on rest and exercise hemodynamics of patients with heart failure and a preserved left ventricular ejection fraction 253
Right Heart Adaptation to Exercise in Pulmonary Hypertension: An Invasive Hemodynamic Study 252
Impact of correcting the 2D PISA method on the quantification of functional tricuspid regurgitation severity 252
Haemodynamic validation of the three-step HFA-PEFF algorithm to diagnose heart failure with preserved ejection fraction 247
Blood pressure response to six-minute walk test in hypertensive subjects exposed to high altitude: Effects antihypertensive combination treatment 247
The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype 245
Right ventricular reserve in cardiopulmonary disease: A simultaneous hemodynamic and three-dimensional echocardiographic study 242
Right heart chambers geometry and function in patients with the atrial and the ventricular phenotypes of functional tricuspid regurgitation 237
The intertwinement of social anxiety, developmental period, and immigrant status in predicting bullying victimization 230
Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component 225
Shedding Light on Latent Pulmonary Vascular Disease in Heart Failure With Preserved Ejection Fraction 224
Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol 222
Right Atrial Remodeling and Outcome in Patients with Secondary Tricuspid Regurgitation 216
Noninvasive versus invasive pressure–flow relationship of the pulmonary circulation: Bias and error 214
Association With Outcome of the Regurgitant-Volume Adjusted Right Ventricular Ejection Fraction in Secondary Tricuspid Regurgitation 208
Blood pressure response in miners exposed to chronic intermittent hypoxia in Chile 207
Systemic Sclerosis and Pulmonary Hypertension: The Great Masquerader 194
Alterations of cardiovascular complexity during acute exposure to high altitude: A multiscale entropy approach 191
Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities 189
An updated meta-analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease 189
Central sleep apnea during continuous positive airway pressure therapy in obstructive sleep apnea patients: From the compliance to adaptation, maladaptation and reflexes 189
Clinical phenotypes, right ventricular function, exercise pathophysiology and outcomes of pulmonary hypertension due to left heart disease: role of the precapillary component 189
Functional Tricuspid Regurgitation and Atrial Fibrillation: Which Comes First, the Chicken or the Egg? 182
Impact of COVID-19 lockdown on exercise capacity in PAH patients 161
Exercise in hypoxia: a model from laboratory to on-field studies 143
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 127
Reply to: 'The hyperdynamic circulatory profile of patients with COVID-19-related acute vascular distress syndrome' 120
Pick Your Threshold: A Comparison Among Different Methods of Anaerobic Threshold Evaluation in Heart Failure Prognostic Assessment 117
The right side of the circulation in not secondary heart failure with preserved ejection fraction: an elephant in the room? 102
Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure With Preserved Ejection Fraction? 79
The Need for Refined Effective Regurgitant Orifice Area Cutoff Values to Define Severe Tricuspid Regurgitation 67
Totale 18.480
Categoria #
all - tutte 57.995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.995


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022556 0 0 0 65 64 27 20 42 51 51 84 152
2022/20231.445 158 374 171 131 107 202 18 85 76 42 40 41
2023/2024996 18 32 56 62 137 251 204 41 54 19 16 106
2024/20253.139 133 267 198 151 281 192 198 112 307 487 305 508
2025/20268.216 1.338 639 481 905 943 335 1.178 296 573 622 404 502
2026/20271.484 338 317 741 88 0 0 0 0 0 0 0 0
Totale 18.480